
|Videos|February 19, 2015
What Pharmacists Should Consider When Evaluating mHealth Options
Timothy Aungst, PharmD, assistant professor of pharmacy practice at MCPHS University, talks about what pharmacists should consider when evaluating mHealth options.
Advertisement
Timothy Aungst, PharmD, assistant professor of pharmacy practice at MCPHS University, talks about what pharmacists should consider when evaluating mHealth options.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
4
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
5

















































































































































































































